REPORTS

Let’s Pullulate and Expand Your Business

Global Cholera Vaccine (Oral Route) Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 14, 2020  |  196 PAGES  |  REPORT CODE: CMM369427
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The Cholera Vaccine (Oral Route) is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 2.5% during the forecast period. The research provides insights for the global Cholera Vaccine (Oral Route) market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Cholera Vaccine (Oral Route) industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Cholera Vaccine (Oral Route) Market Segmentations:

By Players:

  • PaxVax

  • Sanofi

  • Valneva

  • EuBiologics

By Types:

  • Shanchol

  • Dukoral

  • Vaxchora

  • Others

By End-User:

  • Hospital

  • Research & Academic Laboratories

  • Pharmaceutical & Biotechnology Companies

  • Others

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Cholera Vaccine (Oral Route) Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Cholera Vaccine (Oral Route) Market Size and Growth Rate of Shanchol from 2014 to 2026

    • 1.3.2 Global Cholera Vaccine (Oral Route) Market Size and Growth Rate of Dukoral from 2014 to 2026

    • 1.3.3 Global Cholera Vaccine (Oral Route) Market Size and Growth Rate of Vaxchora from 2014 to 2026

    • 1.3.4 Global Cholera Vaccine (Oral Route) Market Size and Growth Rate of Others from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Cholera Vaccine (Oral Route) Market Size and Growth Rate of Hospital from 2014 to 2026

    • 1.4.2 Global Cholera Vaccine (Oral Route) Market Size and Growth Rate of Research & Academic Laboratories from 2014 to 2026

    • 1.4.3 Global Cholera Vaccine (Oral Route) Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies from 2014 to 2026

    • 1.4.4 Global Cholera Vaccine (Oral Route) Market Size and Growth Rate of Others from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Cholera Vaccine (Oral Route) Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Cholera Vaccine (Oral Route) by Major Types

    • 3.4.1 Cholera Vaccine (Oral Route) Market Size and Growth Rate of Shanchol

    • 3.4.2 Cholera Vaccine (Oral Route) Market Size and Growth Rate of Dukoral

    • 3.4.3 Cholera Vaccine (Oral Route) Market Size and Growth Rate of Vaxchora

    • 3.4.4 Cholera Vaccine (Oral Route) Market Size and Growth Rate of Others

4 Segmentation of Cholera Vaccine (Oral Route) Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Cholera Vaccine (Oral Route) by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Cholera Vaccine (Oral Route) in Hospital

    • 4.4.2 Market Size and Growth Rate of Cholera Vaccine (Oral Route) in Research & Academic Laboratories

    • 4.4.3 Market Size and Growth Rate of Cholera Vaccine (Oral Route) in Pharmaceutical & Biotechnology Companies

    • 4.4.4 Market Size and Growth Rate of Cholera Vaccine (Oral Route) in Others

5 Market Analysis by Major Regions

  • 5.1 Global Cholera Vaccine (Oral Route) Production Analysis by Major Regions

  • 5.2 Global Cholera Vaccine (Oral Route) Consumption Analysis by Major Regions

  • 5.3 Global Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

6 Product Commodity of Cholera Vaccine (Oral Route) Market in Major Countries

  • 6.1 Top 5 Export Countries in Cholera Vaccine (Oral Route) market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Cholera Vaccine (Oral Route) market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Cholera Vaccine (Oral Route) market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Cholera Vaccine (Oral Route) market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Cholera Vaccine (Oral Route) market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Cholera Vaccine (Oral Route) market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Cholera Vaccine (Oral Route) Landscape Analysis

  • 7.1 North America Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

  • 7.2 North America Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

  • 7.3 North America Cholera Vaccine (Oral Route) Landscape Analysis by Major Countries

    • 7.3.1 United States Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    • 7.3.2 Canada Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    • 7.3.3 Mexico Cholera Vaccine (Oral Route) Market Volume and Growth Rate

8 Europe Cholera Vaccine (Oral Route) Landscape Analysis

  • 8.1 Europe Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

  • 8.2 Europe Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

  • 8.3 Europe Cholera Vaccine (Oral Route) Landscape Analysis by Major Countries

    • 8.3.1 Germany Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    • 8.3.2 UK Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    • 8.3.3 France Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    • 8.3.4 Italy Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    • 8.3.6 Spain Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    • 8.3.7 Belgium Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    • 8.3.8 Poland Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    • 8.3.9 Russia Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    • 8.3.10 Turkey Cholera Vaccine (Oral Route) Market Volume and Growth Rate

9 Asia Pacific Cholera Vaccine (Oral Route) Landscape Analysis

  • 9.1 Asia Pacific Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

  • 9.2 Asia Pacific Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Cholera Vaccine (Oral Route) Landscape Analysis by Major Countries

    • 9.3.1 China Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    • 9.3.2 Japan Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    • 9.3.4 India Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    • 9.3.6 South Korea Cholera Vaccine (Oral Route) Market Volume and Growth Rate

10 Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    • 10.3.2 Brazil Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    • 10.3.3 Nigeria Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    • 10.3.4 South Africa Cholera Vaccine (Oral Route) Market Volume and Growth Rate 

    • 10.3.5 Argentina Cholera Vaccine (Oral Route) Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 PaxVax

    • 11.1.1 PaxVax Company Profile and Recent Development

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Sanofi

    • 11.2.1 Sanofi Company Profile and Recent Development

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Valneva

    • 11.3.1 Valneva Company Profile and Recent Development

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 EuBiologics

    • 11.4.1 EuBiologics Company Profile and Recent Development

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 92 Figures and 195 Tables)

  • Figure Product Picture

  • Figure Cholera Vaccine (Oral Route) Market Size and Growth Rate of Shanchol from 2014 to 2026

  • Figure Cholera Vaccine (Oral Route) Market Size and Growth Rate of Dukoral from 2014 to 2026

  • Figure Cholera Vaccine (Oral Route) Market Size and Growth Rate of Vaxchora from 2014 to 2026

  • Figure Cholera Vaccine (Oral Route) Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Cholera Vaccine (Oral Route) Market Size and Growth Rate of Hospital from 2014 to 2026

  • Figure Global Cholera Vaccine (Oral Route) Market Size and Growth Rate of Research & Academic Laboratories from 2014 to 2026

  • Figure Global Cholera Vaccine (Oral Route) Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies from 2014 to 2026

  • Figure Global Cholera Vaccine (Oral Route) Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Cholera Vaccine (Oral Route) Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Cholera Vaccine (Oral Route)

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Cholera Vaccine (Oral Route) by Different Types from 2014 to 2026

  • Table Consumption Share of Cholera Vaccine (Oral Route) by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Shanchol

  • Figure Market Size and Growth Rate of Dukoral

  • Figure Market Size and Growth Rate of Vaxchora

  • Figure Market Size and Growth Rate of Others

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Cholera Vaccine (Oral Route) by Different End-Users from 2014 to 2026

  • Table Consumption Share of Cholera Vaccine (Oral Route) by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Hospital

  • Figure Market Size and Growth Rate of Research & Academic Laboratories

  • Figure Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies

  • Figure Market Size and Growth Rate of Others

  • Table Global Cholera Vaccine (Oral Route) Production by Major Regions

  • Table Global Cholera Vaccine (Oral Route) Production Share by Major Regions

  • Figure Global Cholera Vaccine (Oral Route) Production Share by Major Regions in 2014

  • Figure Global Cholera Vaccine (Oral Route) Production Share by Major Regions in 2018

  • Figure Global Cholera Vaccine (Oral Route) Production Share by Major Regions in 2026

  • Table Global Cholera Vaccine (Oral Route) Consumption by Major Regions

  • Table Global Cholera Vaccine (Oral Route) Consumption Share by Major Regions

  • Figure Global Cholera Vaccine (Oral Route) Consumption Share by Major Regions in 2014

  • Figure Global Cholera Vaccine (Oral Route) Consumption Share by Major Regions in 2018

  • Figure Global Cholera Vaccine (Oral Route) Consumption Share by Major Regions in 2026

  • Table North America Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

  • Table Europe Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Cholera Vaccine (Oral Route) market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Cholera Vaccine (Oral Route) market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Cholera Vaccine (Oral Route) market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Cholera Vaccine (Oral Route) market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

  • Table North America Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

  • Figure North America Cholera Vaccine (Oral Route) Consumption Share by Types in 2014

  • Figure North America Cholera Vaccine (Oral Route) Consumption Share by Types in 2018

  • Figure North America Cholera Vaccine (Oral Route) Consumption Share by Types in 2026

  • Table North America Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

  • Table North America Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

  • Figure North America Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2014

  • Figure North America Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2018

  • Figure North America Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2026

  • Table North America Cholera Vaccine (Oral Route) Consumption by Major Countries from 2014 to 2026

  • Table North America Cholera Vaccine (Oral Route) Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Cholera Vaccine (Oral Route) Consumption Share by Major Countries in 2014

  • Figure North America Cholera Vaccine (Oral Route) Consumption Share by Major Countries in 2018

  • Figure North America Cholera Vaccine (Oral Route) Consumption Share by Major Countries in 2026

  • Figure United States Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

  • Table Europe Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

  • Figure Europe Cholera Vaccine (Oral Route) Consumption Share by Types in 2014

  • Figure Europe Cholera Vaccine (Oral Route) Consumption Share by Types in 2018

  • Figure Europe Cholera Vaccine (Oral Route) Consumption Share by Types in 2026

  • Table Europe Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

  • Table Europe Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2014

  • Figure Europe Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2018

  • Figure Europe Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2026

  • Table Europe Cholera Vaccine (Oral Route) Consumption by Major Countries from 2014 to 2026

  • Table Europe Cholera Vaccine (Oral Route) Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Cholera Vaccine (Oral Route) Consumption Share by Major Countries in 2014

  • Figure Europe Cholera Vaccine (Oral Route) Consumption Share by Major Countries in 2018

  • Figure Europe Cholera Vaccine (Oral Route) Consumption Share by Major Countries in 2026

  • Figure Germany Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

  • Figure France Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

  • Table Asia Pacific Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Cholera Vaccine (Oral Route) Consumption Share by Types in 2014

  • Figure Asia Pacific Cholera Vaccine (Oral Route) Consumption Share by Types in 2018

  • Figure Asia Pacific Cholera Vaccine (Oral Route) Consumption Share by Types in 2026

  • Table Asia Pacific Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2014

  • Figure Asia Pacific Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2018

  • Figure Asia Pacific Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2026

  • Table Asia Pacific Cholera Vaccine (Oral Route) Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Cholera Vaccine (Oral Route) Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Cholera Vaccine (Oral Route) Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Cholera Vaccine (Oral Route) Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Cholera Vaccine (Oral Route) Consumption Share by Major Countries in 2026

  • Figure China Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandCholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

  • Figure India Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Consumption Share by Major Countries in 2026

  • Figure GCC Countries Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of PaxVax

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PaxVax

  • Figure Sales and Growth Rate Analysis of PaxVax

  • Figure Revenue and Market Share Analysis of PaxVax

  • Table Product and Service Introduction of PaxVax

  • Table Company Profile and Development Status of Sanofi

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

  • Figure Sales and Growth Rate Analysis of Sanofi

  • Figure Revenue and Market Share Analysis of Sanofi

  • Table Product and Service Introduction of Sanofi

  • Table Company Profile and Development Status of Valneva

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valneva

  • Figure Sales and Growth Rate Analysis of Valneva

  • Figure Revenue and Market Share Analysis of Valneva

  • Table Product and Service Introduction of Valneva

  • Table Company Profile and Development Status of EuBiologics

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of EuBiologics

  • Figure Sales and Growth Rate Analysis of EuBiologics

  • Figure Revenue and Market Share Analysis of EuBiologics

  • Table Product and Service Introduction of EuBiologics


Report Purchase

reports
$4480
$8960
BUY NOWClick MeBUY NOW
top